Matthias Guckenberger

Matthias Guckenberger's AcademicInfluence.com Rankings

Physics

#5766

World Rank

#7636

Historical Rank

physics Degrees

Download Badge

Physics

Why Is Matthias Guckenberger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Matthias Guckenberger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. (2020) (974)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. (2020) (391)
Stereotactic radiotherapy of primary liver cancer and hepatic metastases (2006) (270)
Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? (2009) (224)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. (2020) (213)
Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. (2012) (210)
ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams (2019) (205)
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. (2017) (196)
MR-guidance in clinical reality: current treatment challenges and future perspectives (2019) (191)
A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy (2012) (190)
Investigation of the usability of conebeam CT data sets for dose calculation (2008) (183)
Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. (2009) (181)
Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. (2006) (181)
kV Cone-Beam CT-Based IGRT (2011) (178)
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) (165)
Radiotherapy in adrenocortical carcinoma (2009) (164)
Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis (2013) (158)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma. (2018) (155)
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. (2015) (151)
Definition of stereotactic body radiotherapy (2013) (150)
Four-dimensional treatment planning for stereotactic body radiotherapy. (2007) (149)
Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report. (2019) (148)
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review. (2017) (148)
European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. (2017) (147)
Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. (2010) (144)
Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. (2007) (144)
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement (2020) (143)
Precision of Image-Guided Radiotherapy (IGRT) in Six Degrees of Freedom and Limitations in Clinical Practice (2007) (139)
Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. (2007) (133)
Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table. (2007) (133)
Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis (2014) (132)
Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. (2017) (131)
Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. (2009) (129)
Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. (2014) (129)
Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors (2006) (129)
Influence of inter-observer delineation variability on radiomics stability in different tumor sites (2018) (126)
Is a single respiratory correlated 4D-CT study sufficient for evaluation of breathing motion? (2007) (125)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". (2016) (123)
Stereotactic radiosurgery for treatment of brain metastases (2014) (121)
Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. (2011) (117)
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases (2018) (107)
Transcriptome Analysis of Neisseria meningitidis during Infection (2003) (104)
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. (2013) (103)
Evaluation of an automated knowledge based treatment planning system for head and neck (2015) (103)
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. (2019) (102)
Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. (2017) (101)
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. (2016) (99)
Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer? (2012) (97)
Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors (2012) (96)
Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma (2017) (95)
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. (2015) (95)
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. (2020) (95)
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study (2018) (91)
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective. (2015) (91)
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. (2020) (90)
Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery (2012) (87)
Modern therapeutic approaches for the treatment of malignant liver tumours (2020) (86)
Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation. (2016) (84)
A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy (2012) (83)
Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. (2008) (82)
Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. (2015) (82)
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery (2020) (81)
A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking (2016) (80)
Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models. (2017) (78)
Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy. (2010) (75)
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. (2017) (74)
Reliability of the bony anatomy in image-guided stereotactic radiotherapy of brain metastases. (2007) (73)
Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. (2010) (72)
Nonrigid Patient Setup Errors in the Head-and-Neck Region (2007) (71)
Stereotactic body radiation therapy in the re-irradiation situation – a review (2013) (71)
Intensity-Modulated Radiotherapy (IMRT) of Localized Prostate Cancer (2007) (70)
Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. (2011) (70)
Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): system description and prototype testing. (2008) (69)
Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. (2017) (69)
Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT). (2007) (68)
Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer (2010) (66)
Stereotactic body radiotherapy for liver tumors (2014) (65)
Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer (2008) (62)
Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy (2017) (61)
Intensity-modulated radiotherapy for lung cancer: current status and future developments. (2014) (60)
Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. (2016) (60)
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement (2020) (57)
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. (2014) (54)
Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group. (2012) (53)
Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): System description and prototype testing. (2008) (53)
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases (2019) (52)
Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives. (2007) (52)
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) (52)
Transcriptome-based antigen identification for Neisseria meningitidis. (2003) (51)
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (50)
Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer. (2012) (50)
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition (2020) (49)
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial (2020) (49)
Tracking moving objects with megavoltage portal imaging: a feasibility study. (2006) (49)
Late small bowel toxicity after adjuvant treatment for rectal cancer (2006) (48)
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. (2017) (47)
Stability of radiomic features in CT perfusion maps (2016) (47)
Analysis of the Heat Shock Response of Neisseria meningitidis with cDNA- and Oligonucleotide-Based DNA Microarrays (2002) (46)
Clinical practice of image-guided spine radiosurgery - results from an international research consortium (2011) (45)
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction (2018) (45)
SBRT for oligoprogressive oncogene addicted NSCLC. (2017) (44)
Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa). (2016) (44)
Spinal metastases: Is stereotactic body radiation therapy supported by evidences? (2016) (44)
Influence of retrospective sorting on image quality in respiratory correlated computed tomography. (2007) (43)
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease. (2017) (42)
Hypofractionated radiotherapy for prostate cancer (2014) (42)
Effect of Breathing Motion in Radiotherapy of Breast Cancer (2009) (42)
Image guidance in radiation therapy for better cure of cancer (2020) (42)
Progression-free and overall survival for concurrent nivolumab with standard concurrent chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: Results from the European Thoracic Oncology Platform NICOLAS phase II trial (ETOP 6-14). (2020) (42)
First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardia. (2020) (42)
Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy (2018) (42)
ITV, mid-ventilation, gating or couch tracking - A comparison of respiratory motion-management techniques based on 4D dose calculations. (2017) (42)
Technology‐driven research for radiotherapy innovation (2020) (41)
Stereotactic body radiotherapy for centrally located stage I NSCLC (2014) (41)
CT radiomics and PET radiomics: ready for clinical implementation? (2019) (40)
Planning benchmark study for SBRT of early stage NSCLC (2017) (40)
Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer (2018) (40)
Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer (2019) (39)
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. (2021) (39)
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy". (2017) (39)
A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept --a compromise between small safety margins and long duty cycles. (2011) (38)
Evolution of treatment strategies for oligometastatic NSCLC patients - A systematic review of the literature. (2019) (38)
Does Intensity Modulated Radiation Therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? (2008) (37)
Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. (2016) (37)
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (37)
Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. (2018) (37)
Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer. (2013) (36)
Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer (2012) (36)
Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (36)
LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation (2019) (35)
Motion compensation in radiotherapy. (2012) (35)
Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy. (2015) (33)
Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development (2020) (32)
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation. (2019) (32)
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. (2018) (32)
Comparison of a multileaf collimator tracking system and a robotic treatment couch tracking system for organ motion compensation during radiotherapy. (2012) (32)
Moderately hypofractionated radiotherapy for localized prostate cancer (2013) (31)
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. (2019) (31)
Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (31)
Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer. (2018) (29)
Feasibility and Usability Aspects of Continuous Remote Monitoring of Health Status in Palliative Cancer Patients Using Wearables (2019) (29)
Prediction of Early Death in Patients with Early‐Stage NSCLC—Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach? (2016) (29)
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? (2019) (29)
Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases. (2009) (29)
Distinct effects of rectum delineation methods in 3D-confromal vs. IMRT treatment planning of prostate cancer (2006) (28)
Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results (2010) (28)
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer (2020) (28)
Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (28)
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial. (2019) (28)
Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL (2019) (28)
Treatment plan quality during online adaptive re-planning (2020) (27)
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (27)
Influence of continuous table motion on patient breathing patterns. (2010) (27)
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT. (2019) (27)
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis (2018) (27)
Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments. (2016) (26)
Mid-ventilation concept for mobile pulmonary tumors: internal tumor trajectory versus selective reconstruction of four-dimensional computed tomography frames based on external breathing motion. (2009) (26)
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial (2012) (26)
Mobile Health Technologies for Continuous Monitoring of Cancer Patients in Palliative Care Aiming to Predict Health Status Deterioration: A Feasibility Study. (2019) (26)
Stereotactic Radiosurgery for Multiple Brain Metastases (2019) (25)
The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy (2017) (25)
A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015 (2016) (24)
Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals. (2013) (24)
Evolution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC) (2009) (24)
The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases (2018) (24)
Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. (2015) (24)
Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments. (2020) (24)
Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer. (2006) (24)
SBRT for centrally localized NSCLC – What is too central? (2016) (23)
Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study (2018) (23)
Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous (2019) (23)
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer (2019) (23)
Influence of Rectum Delineation (Rectal Volume vs. Rectal Wall) on IMRT Treatment Planning of the Prostate (2006) (23)
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? (2019) (23)
Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity (2018) (23)
Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas (2014) (22)
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial. (2018) (22)
Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC). (2019) (22)
Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries (2015) (22)
Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis (2021) (21)
Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. (2019) (21)
Short interactive workshops reduce variability in contouring treatment volumes for spine stereotactic body radiation therapy: Experience with the ESTRO FALCON programme and EduCase™ training tool. (2017) (20)
Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150. (2009) (20)
Dose‐intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study (2018) (20)
Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. (2013) (20)
Radiomic biomarkers for head and neck squamous cell carcinoma (2020) (20)
Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results (2009) (20)
Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme (2011) (20)
Optimization of combined proton-photon treatments. (2018) (19)
Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy. (2014) (19)
A comparison between 2-Step IMRT and conventional IMRT planning. (2007) (19)
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. (2013) (19)
Validation of dynamic treatment‐couch tracking for prostate SBRT (2017) (19)
Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries (2019) (19)
Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases (2014) (19)
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives☆ (2020) (18)
Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer (2018) (18)
Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases. (2016) (18)
Predisposing and precipitating risk factors for delirium in palliative care patients (2019) (18)
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (18)
Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer (2012) (17)
Comparison of Wedge versus Segmented Techniques in Whole Breast Irradiation (2008) (17)
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). (2019) (17)
Variability in spine radiosurgery treatment planning – results of an international multi-institutional study (2012) (17)
Interchangeability of radiomic features between [18F]‐FDG PET/CT and [18F]‐FDG PET/MR (2019) (17)
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database (2021) (17)
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. (2015) (17)
Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925. (2021) (17)
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma (2020) (17)
Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group (2017) (17)
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients (2020) (17)
“HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer (2017) (17)
ELPHA: Dynamically deformable liver phantom for real‐time motion‐adaptive radiotherapy treatments (2019) (17)
Performance comparison of prediction filters for respiratory motion tracking in radiotherapy. (2019) (17)
mHealth Technologies for Palliative Care Patients at the Interface of In-Patient to Outpatient Care: Protocol of Feasibility Study Aiming to Early Predict Deterioration of Patient’s Health Status (2017) (17)
Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients. (2020) (16)
Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer (2016) (16)
Preserving the legacy of reirradiation: A narrative review of historical publications (2017) (16)
Second re-irradiation: a narrative review of the available clinical data (2017) (16)
Comparison of multi-leaf collimator tracking and treatment-couch tracking during stereotactic body radiation therapy of prostate cancer. (2017) (16)
Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis. (2022) (16)
Recommendations regarding cardiac stereotactic body radiotherapy for treatment-refractory ventricular tachycardia. (2021) (16)
Carbon Fiber/Polyether Ether Ketone (CF/PEEK) Implants Allow for More Effective Radiation in Long Bones (2020) (16)
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study (2020) (15)
A multi-national report on methods for institutional credentialing for spine radiosurgery (2013) (15)
Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT. (2019) (15)
Non-parametric intravoxel incoherent motion analysis in patients with intracranial lesions: Test-retest reliability and correlation with arterial spin labeling (2016) (15)
Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria (2018) (15)
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long‐Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01) (2019) (14)
Patterns of Care in the Radiotherapy of Prostate Cancer in Northern Bavaria 1998–2000 (2007) (14)
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy. (2019) (14)
Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy (2008) (14)
Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. (2018) (14)
Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: A Synthesis of International Practice Patterns to Guide Treatment Planning. (2020) (13)
Radiation recall dermatitis induced by sorafenib (2016) (13)
Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations (2018) (13)
Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study. (2019) (13)
Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss. (2019) (13)
Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease (2017) (13)
Prospective randomized clinical studies involving reirradiation (2016) (13)
Radiomics Feature Activation Maps as a New Tool for Signature Interpretability (2020) (12)
Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation (2012) (12)
Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or "no-go"? (2013) (12)
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis (2021) (12)
Current status and recent advances in resection cavity irradiation of brain metastases (2021) (12)
Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer. (2017) (12)
Four Dimensional Target Volume Generation in Pulmonary Stereotactic Body Radiotherapy (2007) (12)
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy (2018) (12)
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis (2021) (12)
Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types. (2021) (12)
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020) (12)
Re-irradiation in the thorax - An analysis of efficacy and safety based on accumulated EQD2 doses. (2020) (11)
Three-dimensional spatial modelling of the correlation between abdominal motion and lung tumour motion with breathing (2006) (11)
Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis. (2019) (11)
Image-guided Radiotherapy Based on Kilovoltage Cone-beam Computed Tomography - A Review of Technology and Clinical Outcome (2011) (11)
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer (2017) (11)
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. (2022) (11)
Distance to Isocenter is not associated with an increased risk for Local Failure in LINAC-based Single-Isocenter Stereotactic Radiosurgery (SRS) or Radiotherapy (SRT) for Multiple Brain Metastases. (2021) (11)
Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next? (2015) (11)
Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy. (2017) (11)
Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial (2021) (11)
A multinational pooled analysis of 434 cases of stage I non-small cell lung cancer (NSCLC) treated with volumetrically image-guided (VIGRT) stereotactic lung radiotherapy (SBRT): Results from the Elekta Collaborative Lung Research Group. (2010) (11)
Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report (2018) (11)
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial (2020) (10)
Technical know‐how in stereotactic ablative radiotherapy (SABR) (2016) (10)
Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes (2021) (10)
Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study (2019) (10)
Absenteeism and presenteeism in healthcare workers due to respiratory illness (2020) (10)
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists (2021) (10)
The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. (2020) (10)
Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma (2019) (10)
SBRT in operable early stage lung cancer patients. (2014) (10)
An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer (2021) (9)
Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine. (2014) (9)
Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy. (2016) (9)
Combined proton-photon treatments - A new approach to proton therapy without a gantry. (2020) (9)
World Congress Integrative Medicine & Health 2017: part two (2017) (9)
Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer (2017) (9)
Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results. (2019) (9)
Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC: Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial (2019) (9)
Risk for surgical complications after previous stereotactic body radiotherapy of the spine (2017) (8)
Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy. (2022) (8)
Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance (2010) (8)
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy (2020) (8)
Dosimetric and geometric end-to-end accuracy of a magnetic resonance guided linear accelerator (2020) (8)
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study (2019) (8)
A Bayesian network model of lymphatic tumor progression for personalized elective CTV definition in head and neck cancers (2019) (8)
Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users (2021) (8)
MA25.02 Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts (2018) (8)
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. (2020) (8)
Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy (2020) (7)
The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. (2017) (7)
Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch. (2022) (7)
Changes in penile bulb dose when using the Clarity transperineal ultrasound probe: A planning study. (2016) (7)
Perspectives on oligometastasis: challenges and opportunities. (2018) (7)
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology (2021) (7)
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (7)
Dose-intensified versus conventional dose-salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: Six-year outcomes of the SAKK 09/10 randomized phase III trial. (2021) (7)
Studies on the role of osteopontin-1 in endometrial cancer cell lines (2013) (7)
Incidence and survival of patients with oligometastatic esophagogastric cancer: a multicenter cohort study. (2022) (7)
Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study. (2022) (7)
Modeling and performance evaluation of a robotic treatment couch for tumor tracking (2016) (7)
The development of stereotactic body radiotherapy in the past decade: a global perspective. (2015) (7)
Developing an Integrative Treatment Program for Cancer-Related Fatigue Using Stakeholder Engagement – A Qualitative Study (2017) (7)
Radiation holidays stimulate tumor immunity (2015) (7)
Assessment of extracranial metastatic disease in patients with brain metastases: how much effort is needed in the context of evolving survival prediction models? (2021) (7)
Radiotherapy of the oldest old—feasibility and institutional analysis (2020) (7)
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy. (2007) (7)
Single-isocenter versus multiple-isocenters for multiple lung metastases: evaluation of lung dose (2021) (6)
Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study (2021) (6)
Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy (2019) (6)
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer (2021) (6)
LONG-TERM RESULTS OF DOSE-INTENSIFIED FRACTIONATED STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR PAINFUL SPINAL METASTASES. (2021) (6)
Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.). (2008) (6)
Oligoprogression: Eine innovative Indikation für die Körperstereotaxie bei metastasierten Tumorsituationen (2015) (6)
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer. (2021) (6)
Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancer. (2007) (6)
Imaging-based prevalence of oligometastatic disease: A single-center cross-sectional study. (2022) (6)
The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion. (2019) (6)
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis (2021) (6)
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis (2020) (6)
Interobserver variability in target volume delineation of hepatocellular carcinoma (2017) (6)
The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: results from the EORTC 22922/10925 randomised trial. (2022) (6)
Tumor Oxygenation by Myo-Inositol Trispyrophosphate Enhances Radiation Response. (2021) (6)
A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question? (2015) (5)
68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer (2021) (5)
Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis (2022) (5)
Underweight and weight loss are predictors of poor outcome in patients with brain metastasis (2019) (5)
Dosimetric consequences of inter-fraction breathing-pattern variation on radiotherapy with personalized motion-assessed margins (2011) (5)
Erratum to “Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study” [Radiother Oncol 85 (2007) 435–442] (2008) (5)
Die deutsche S3-Leitlinie zum Nierenzellkarzinom (2017) (5)
High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation (2021) (5)
MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands (2021) (5)
The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas (2021) (5)
Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking. (2020) (5)
Secondary attack rates from asymptomatic and symptomatic influenza virus shedders in hospitals: Results from the TransFLUas influenza transmission study (2021) (5)
Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: A long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis. (2019) (5)
An international Delphi consensus for pelvic Stereotactic Ablative Radiotherapy re-irradiation. (2021) (5)
Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (5)
On the use of a hexapod table to improve tumour targeting in radiation therapy (2007) (5)
TRANSPERINEAL INJECTION OF HYALURONIC ACID IN ANTERIOR PERIRECTAL FAT TO DECREASE RECTAL TOXICITY FROM RADIATION DELIVERED WITH INTENSITY-MODULATED BRACHYTHERAPY OR EBRT FOR PROSTATE CANCER PATIENTS : IN REGARD TO PRADA ET AL. Authors' reply (2008) (5)
Analysis of lymphatic metastasis and progression patterns for clinical target volume (CTV) definition in head and neck squamous cell carcinoma (HNSCC) (2019) (5)
Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience (2021) (5)
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) (4)
[German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist]. (2018) (4)
Validation of high-risk CT features for detection of local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer (4)
SBRT for Central Tumors in Early Stage NSCLC Patients (2017) (4)
4D-CT-based motion correction of PET images using 3D iterative deconvolution (2019) (4)
Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study (2022) (4)
Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. (2021) (4)
A pattern of care analysis: Prosthetic rehabilitation of head and neck cancer patients after radiotherapy. (2020) (4)
Systematic Review on the Association of Radiomics with Tumor Biological Endpoints (2021) (4)
MR-guided beam gating: Residual motion, gating efficiency and dose reconstruction for stereotactic treatments of the liver and lung. (2022) (4)
Combining deep learning and radiomics to predict HPV status in oropharyngeal squamous cell carcinoma (2018) (4)
Monitoring Patients in Ambulatory Palliative Care: A Design for an Observational Study (2016) (4)
What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer? (2011) (4)
Long-term cancer survivors treated with multiple courses of repeat radiation therapy (2021) (4)
[Image-guided radiation therapy]. (2012) (4)
NTCP Modeling for Radiation Pneumonitis after SBRT for Malignant Pulmonary Lesions: Results of a Multi-institutional Analysis (2011) (4)
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective. (2022) (4)
Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches (2017) (4)
SBRT Dose and Survival in Non-Small Cell Lung Cancer: In Regard to Koshy et al. (2015) (4)
In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO) (2021) (4)
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research (2021) (4)
Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis (2020) (3)
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy (2022) (3)
125: HALT: Targeted therapy beyond progression with or without dose-intensified radiotherapy in oligoprogressive disease in oncogene addicted lung tumours (2017) (3)
OC-0061 EORTC 22113-8113 Lungtech trial on SBRT of central lung tumors (2019) (3)
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study (2019) (3)
Abstract LB-151: The novel tubulin-binding, tumor checkpoint controller BAL101553 has differential effects on tumor vascularization with IV and oral dosing and provides superior anti-tumor activity in combination with bevacizumab (2017) (3)
Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery (2012) (3)
Accounting for range uncertainties in the optimization of combined proton-photon treatments via stochastic optimization. (2020) (3)
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose (2021) (3)
Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface (2021) (3)
Planning benchmark study for SBRT of liver metastases: Results of the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. (2022) (3)
OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice (2016) (3)
SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation. (2016) (3)
Body motion during dynamic couch tracking with healthy volunteers (2018) (3)
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (3)
1042 : Cone-Beam CT Based Image-Guidance for Hypofractionated Radiotherapy of Intrapulmonary Lesions - Evaluation of Benefits and Limitations (2006) (3)
Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study. (2022) (3)
OC-0399: Dose to heart substructures is associated with non-cancer death after SBRT in stage I NSCLC patients (2016) (3)
Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC) (2010) (3)
A 2.5D convolutional neural network for HPV prediction in advanced oropharyngeal cancer (2022) (3)
Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma (2021) (3)
Recommendations for Radiation Therapy in Oligometastatic Prostate Cancer: an ESTRO-ACROP Delphi consensus. (2022) (3)
Stereotaktische Strahlentherapie bei Lungenkrebs im Stadium I – gibt es eine Evidenz? (2017) (3)
Focal Radiotherapy of Brain Metastases in Combination With Immunotherapy and Targeted Drug Therapy. (2021) (3)
Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) (3)
Comparison of beam segment versus full plan re-optimization in daily magnetic resonance imaging-guided online-adaptive radiotherapy (2021) (3)
Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective (2022) (3)
Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma. (2018) (3)
37 – Stage I Nonsmall Cell Lung Cancer and Oligometastatic Disease (2018) (3)
Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice (2018) (3)
International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiotherapy for Non-Spine Bone Metastases. (2021) (3)
[Abscopal responses of local radiotherapy combined with systemic immunotherapy in patients with metastatic solid tumors]. (2016) (3)
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging (2021) (3)
Response letter: Handling of COVID-19 positive lung cancer patients during the pandemic☆ (2020) (3)
Stereotaktische Strahlentherapie von Metastasen (2014) (3)
Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC (2021) (2)
Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies (2019) (2)
OC-0445: Patterns of care and outcome analysis of SBRT for liver metastases - a DEGRO database initiative (2016) (2)
Stereotactic body radiotherapy of adrenal metastases—A dose‐finding study (2022) (2)
Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors (2012) (2)
Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease. (2019) (2)
[Evidence for the use of modern irradiation techniques for non-small cell lung cancer: unnecessary, inadequate, insufficient or too late?]. (2012) (2)
EP-2197: Dose normalization in lung SBRT based on ICRU 91 and comparison to alterative normalization methods (2018) (2)
Correction to: Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (2)
Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model (2022) (2)
Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life (2022) (2)
A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction—A Technical Feasibility and Stability Study (2022) (2)
[Stereotactic body radiotherapy for malignant nodules in the lung]. (2013) (2)
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer. (2022) (2)
First two MRI guided stereotactic body radiation therapy of recurrent sustained ventricular tachycardia (2020) (2)
A feasibility trial evaluating the addition of nivolumab to standard first-line chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: The ETOP 6-14 NICOLAS trial (2017) (2)
The ideal couch tracking system—Requirements and evaluation of current systems (2019) (2)
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards (2022) (2)
Optimal Imaging Follow-up Schedules after Stereotactic Ablative Radiotherapy for Early Non-Small-Cell Lung Cancer: Findings of an International Delphi Consensus Study (2017) (2)
Unconscious physiological response of healthy volunteers to dynamic respiration-synchronized couch motion (2017) (2)
Margin calculation for multiple lung metastases treated with single-isocenter SBRT. (2021) (2)
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer (2022) (2)
Definition of Oligometastatic Disease from a Radiation Oncology perspective : 1 an ESTRO-ASTRO Consensus Document 2 3 (2019) (2)
Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis (2010) (2)
Nomogram for predicting overall survival after stereotactic body radiotherapy for pulmonary metastases: Development and external validation: 198PD (2016) (2)
STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES IN LONG BONES. (2022) (2)
Completeness of reporting oligometastatic disease characteristics in literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature. (2022) (2)
Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer. (2022) (2)
International Consensus Contouring Recommendations for Stereotactic Body Radiotherapy of Non-Spine Bone Metastases (2020) (2)
Probing spatiotemporal fractionation on the preclinical level (2020) (2)
SBRT for Lung Metastases: A Pooled Analysis of 651 Patients and 868 Lesions of the German Working Group Stereotactic Radiotherapy (2014) (2)
[Role of stereotactic body radiation therapy for unresected pancreatic cancer]. (2018) (2)
Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy (2021) (2)
Distant metastasis velocity as a novel prognostic score for overall survival after disease progression following stereotactic body radiotherapy for oligometastatic disease. (2022) (2)
Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung. (2022) (2)
Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease? (2021) (2)
PO-0926: Dosimetric comparison of different motion management techniques (2015) (2)
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium. (2023) (2)
Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus? (2022) (2)
Impact of image filtering and assessment of volume-confounding effects on CT radiomic features and derived survival models in non-small cell lung cancer (2021) (2)
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial (2022) (2)
Extrakranielle stereotaktische Bestrahlung bei Lungenrundherden (2013) (2)
Stellenwert der stereotaktischen Radiotherapie für das nichtresezierte Pankreaskarzinom (2018) (2)
Lokal ablative nichtchirurgische Verfahren beim nichtkleinzelligen Bronchialkarzinom (2011) (2)
Kein Nachweis einer Ergebnisverbesserung der Salvage-Radiotherapie beim asymptomatischen biochemischen Prostatakarzinom rezidiv nach Prostatektomie durch additive Androgensuppression (2016) (2)
[Image-guided intensity-modulated radiation therapy decreases late gastrointestinal side effects after radiation therapy for prostate cancer]. (2017) (1)
High-dose re-irradiation of intracranial lesions – Efﬁcacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation Clinical and Translational Radiation Oncology (2021) (1)
Performance behavior of prediction filters for respiratory motion compensation in radiotherapy (2017) (1)
TH‐AB‐304‐06: Investigation of Fractionation Issues in NTCP Modeling of Pneumonitis: An Analysis of Common NTCP Models for Hypo‐Fractionated and Standard‐Fractionated Data (2015) (1)
A Multinational Report on Methods for Delivery of Lung Stereotactic Radiotherapy (SBRT) using Online Volumetric Image-guidance (VIGRT): Results from the Synergy Research Group (2009) (1)
Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation (2012) (1)
A multi-national report on methods for institutional credentialing for spine radiosurgery (2012) (1)
1417TiP Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial (2020) (1)
Radiotherapy for glioblastoma patients with poor performance status (2021) (1)
X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (1)
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer. (2022) (1)
PV-0315 A risk assessment method including credible intervals for lymphatic metastatic spread for HNSCC (2019) (1)
Poster ViewingAn International Radiosurgery Consortium Survey for Gynecological Stereotactic Ablative Radiation Therapy (2017) (1)
A Multi-national Pooled Analysis of 434 Cases of Stage I Non-small Cell Lung Cancer (NSCLC) Treated with Volumetrically Image-guided Stereotactic Lung Radiotherapy: Results from the Elekta Collaborative Lung Research Group (2010) (1)
Grundlagen der Oligometastasierung und Stellenwert der Lokaltherapie (2020) (1)
Influence of Delineation of the Proximal and Distal Rectum as Separated Organ-at-Risks on IMRT Treatment Planning for the Prostate (2005) (1)
Stereotactic body radiation therapy in the re-irradiation situation – a review (2013) (1)
OC-0056: SBRT for lung metastases: detailed subgroup analysis of 700 patients diagnosed with 963 lung metastases (2015) (1)
Intrafraction Variation of Target Position During Cone-beam CT Image-guided Stereotactic Body Radiotherapy (SBRT) for Early-stage Non-small Cell Lung Cancer: A Collaborative Analysis (2011) (1)
Lokale Radiotherapie für Patienten mit einem neu diagnostizierten, metastasierten Prostatakarzinom (2019) (1)
Radiotherapy dose escalation in locally advanced NSCLC - The limits of conventional radiochemotherapy. (2018) (1)
[Palliative Radiotherapy - An Important Tool in the Event Of Painful Bone Metastases]. (2021) (1)
Paradigmenwechsel für stereotaktische Strahlentherapie bei Oligometastasierung (2019) (1)
A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma (2022) (1)
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. (2023) (1)
PD-0740 Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare (2021) (1)
OC-0025 COMPARISON OF A MLC AND A HEXAPOD TRACKING SYSTEM FOR ORGAN MOTION COMPENSATION DURING RADIOTHERAPY (2012) (1)
OC-0626 Toxicity of SRT combined with targeted agents: prospective analysis of the TOaSTT database (2021) (1)
Konsolidierende Lokaltherapie verbessert progressionsfreies Überleben von Patienten mit oligometastasiertem NSCLC (2017) (1)
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis. (2022) (1)
FDG-PET Imaging for Advanced Radiotherapy Treatment of Non-Small-Cell Lung Cancer (2015) (1)
Körperstereotaktische Bestrahlung als „Erstlinientherapie“ des oligometastasierten Nierenzellkarzinoms (2022) (1)
An interlaced IMRT technique for elongated tumor volumes. (2009) (1)
In Regard to Ohri et al. (2019) (1)
Evidenz für den Einsatz moderner Bestrahlungstechniken beim nicht-kleinzelligen Bronchialkarzinom: unnötig, ungenügend, ausreichend oder zu spät? (2012) (1)
Inhibition of N-Myc down regulated gene 1 in in vitro cultured human glioblastoma cells. (2012) (1)
Estimation of the a / b ratio of non-small cell lung cancer treated with stereotactic body radiotherapy (2019) (1)
Optimizing a perfusion CT protocol for head and neck cancer (2017) (1)
Bildgeführte intensitätsmodulierte Strahlentherapie vermindert die gastrointestinalen Spätfolgen nach Radiotherapie des Prostatakarzinoms (2017) (1)
Delta-radiomics for prediction of pseudoprogression in malignant melanoma treated with immune checkpoint inhibition. (2019) (1)
EP-1684: Mobile health technology in severely ill patients (2018) (1)
Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival. (2019) (1)
Treatment plan quality during online adaptive re-planning (2020) (1)
Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis (2014) (1)
Abskopale Effekte der lokalen Radiotherapie in Kombination mit systemischer Immuntherapie bei Patienten mit metastasierten soliden Tumoren (2015) (1)
Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous (2019) (1)
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database (2021) (1)
SBRT in eight fractions. (2017) (1)
EP-2108: Robustness study on radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR (2018) (1)
PV-0312 Distributed learning in radiomics to predict overall survival in head and neck cancer (2019) (1)
OC-0592: Implementation of MR-only one-day radiosurgery workflow for non-spinal bone metastases on MR-Linac (2020) (1)
Palliative Radiotherapie – ein wichtiges Instrument bei schmerzhaften Knochenmetastasen (2021) (1)
TH-AB-303-01: Benchmarking Real-Time Adaptive Radiotherapy Systems: A Multi- Platform Multi-Institutional Study (2015) (1)
[Stereotactic Body Radiotherapy for Early Stage NSCLC - What Is the Evidence?] (2017) (1)
A Collaborative Analysis of Stereotactic Lung Radiotherapy (Lung SBRT) Outcomes for Stage I Non-small Cell Lung Cancer (NSCLC) using Daily Online Cone-beam CT Image-guided Radiotherapy (CBCT-IGRT) (2010) (1)
Variability of Spinal Cord Definition Using MR T2 Versus CT Myelography for Spine Radiosurgery (2015) (1)
Reduced Normal Tissue Doses Through Advanced Technology (2010) (1)
Indikationen zur neoadjuvanten oder definitiven Radiochemotherapie beim Ösophaguskarzinom auf höchstem Evidenzniveau gesichert (2012) (1)
EP-1910 CT image standardization is superior to larger but heterogeneous datasets for robust radiomic models (2019) (1)
Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence? (2015) (1)
Kein Überlebensvorteil durch 5-FU-basierte adjuvante Chemotherapie (2014) (1)
intracranial high precision radiotherapy; first phantom and clinical results (2010) (1)
[Local consolidative therapy improves progression-free survival in patients with oligometastatic NSCLC : Results of a randomized phase II study]. (2017) (1)
OC-0513: In-silico comparison of five automated treatment planning solutions for primary head and neck cancer (2018) (1)
Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (1)
[Indications for neoadjuvant or definitive radiochemotherapy in esophageal cancer of the highest evidence quality]. (2012) (1)
Osteopontin Plasma Levels in Head and Neck Cancer Patients During Radiotherapy (2010) (1)
Stereotactic Body Radiotherapy (2017) (1)
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition (2022) (1)
Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics (2020) (1)
OP0150 MACHINE LEARNING APPROACHES FOR RISK MODELLING IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS USING HIGH DIMENSIONAL IMAGE ANALYSIS (2021) (1)
Expiration Breath-Hold for SBRT in Liver and Abdominal Tumors (2019) (1)
Postgraduate education in radiation oncology during the COVID-19 pandemic – What did we learn? (2022) (1)
Predictive Value of Radiomics Analysis for Local Tumor Control After Radiochemotherapy in Patients With Head and Neck cancer (2016) (1)
No Difference in Outcome Between Biopsied Versus Nonbiopsied Early Stage Medically Inoperable Non-small Cell Lung Cancer Patients Treated With Volumetric Image Guided Stereotactic Body Radiation Therapy (SBRT): Analysis of a Large Multi-institutional Database (2012) (1)
Multimodality Imaging for Planning and Assessment in Radiation Therapy (2018) (1)
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (0)
PV-0044: Repeat sbrt for pulmonary oligo-metastases (2018) (0)
Transferability of radiomic signatures from experimental to human interstitial lung disease (2022) (0)
PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis (2019) (0)
Erratum to: Strahlentherapie und Onkologie, Volume 186 (No. 10) Guckenberger M, Ok S, Polat B, Sweeney RA, Flentje M. Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer. Strahlenther Onkol 2010;186:535–43 (DOI 10.1007/s00066-010-2144-z) (2010) (0)
Thorax (2019) (0)
Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue (2020) (0)
SP-0272: The role of tumor growth models for CTV definition (2020) (0)
SP-0375: The role of radiotherapy in current management of oligometastatic patients (2020) (0)
Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer. (2023) (0)
PO-1804 Local radiomics and clinical variables to predict radiation-induced pneumonitis in NSCLC patients (2021) (0)
Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy (2021) (0)
Durvalumab and tremelimumab plus local tumor ablation (RFA or stereotactic radiotherapy) in patients with metastatic colorectal cancer with unresectable liver metastases: Results of the EORTC-1560-GITCG (ILOC) phase II study. (2023) (0)
[In Process Citation]. (2016) (0)
SP-0545 Clinical perspective and evidence on RT adaptation, has it improved outcome? (2019) (0)
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP) (2022) (0)
POSTER DISCUSSION: 4: CLINICAL: PROSTATEPD-0137: Generation of geometrically adaptable IMAT plans for prostate cancer treatment (2013) (0)
PO-1110 Clinical experience with a radiofrequency system for setup and motion monitoring of prostate radiotherapy (2015) (0)
P05.29 Improvement of stereotactic radiosurgery plan quality with multiple non-coplanar VMAT beams (2018) (0)
IGRT IN RADIOTHERAPY: A PRACTICAL UPDATE ON TECHNOLOGIES (2009) (0)
P-198STEREOTACTIC BODY RADIATION THERAPY AS SALVAGE THERAPY FOR OLIGOMETASTATIC PLEURAL MESOTHELIOMA AFTER CURATIVE INTENT MULTI-MODAL THERAPY (2017) (0)
PH-0435 ADAM17-dependent paracrine and intercellular communication in response to irradiation (2021) (0)
OC-0362 What to expect from MR-guided beam gating: Residual motion, efficiency and dose reconstruction (2021) (0)
Systemischer Effekt einer lokalen Strahlentherapie: erste klinische Evidenz (2021) (0)
OC-0275 Safety and efficacy of concurrent SRT and targeted- or immunotherapy for melanoma brain metastases (2019) (0)
Organ preservation by induction chemotherapy and CT-based 3D radiotherapy in patients with advanced laryn geal and hypopharyngeal carcinomas (2007) (0)
[Palliative radiotherapy - alleviating symptoms and improving quality of life]. (2016) (0)
PO-0653: Surgical interventions after previous SBRT of the spine - increased risk for complications? (2016) (0)
OC-0453: Efficacy and safety of stereotactic radiotherapy combined with TKIs for metastatic lesions. (2020) (0)
PO-1829 Development and optimization of a modulated arc technique for total body irradiation radiotherapy (2021) (0)
MLTI-09. UNDERWEIGHT AND WEIGHT LOSS ARE PREDICTORS OF POOR OUTCOME IN PATIENTS WITH BRAIN METASTASIS (2019) (0)
Spinal Radiosurgery after Radiation Therapy XRT or Radiosurgery (2014) (0)
Results of the Planning Comparison Study SBRT of NSCLC (2015) (0)
403 INVITED Role of Stereotactic Radiotherapy (2011) (0)
EP-1188: Repeat Radiosurgery for new brain metastases allows avoidance of whole-brain radiation therapy (2018) (0)
Poster ViewingMinimizing Immunosuppressive Effects of Photon and Proton Radiation Therapy on Circulating Lymphocytes (2017) (0)
Extra-cranial SBRT in patients with oligometastatic disease: a dose-escalation study (2016) (0)
549 speaker THE CURRENT STATUS OF STEREOTACTIC BODY RADIOTHERAPY (2011) (0)
Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue (2020) (0)
Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: An International Survey of Practice Patterns (2019) (0)
EP-2001: A Bayesian network model for personalized elective CTV definition in head and neck cancer (2018) (0)
SP-0385: Focus on lung cancer: What a radiotherapy department should offer their patients (2017) (0)
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline (2023) (0)
SAT0569 “IMAGES ARE MORE THAN PICTURES, THEY ARE DATA” [1] – EXPLORATION OF RADIOMICS ANALYSIS FOR SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (2020) (0)
PV-0475: Stereotactic Body Radiation Therapy For Painful Spinal Metastases - Results Of A Phase 2 Study (2018) (0)
PD-0050: Predictors and patterns of regional recurrence following lung SBRT: A report from the Elekta Lung Research Group (2015) (0)
Development of an updated, standardized, patient-centered outcome set for lung cancer. (2022) (0)
PO-1169: Influence of localisation of PSMA-positive oligo-metastases on efficacy of metastasis-directed EBRT (2020) (0)
Beeinflussung der Strahlenfibrose unter Verwendung von Decorin und TGFbeta-Antikörpern (2005) (0)
PO-0980: Primary tumor and lymph nodes CT radiomics to predict loco-regional control in head and neck cancer (2018) (0)
OC-0645 Head and neck radiotherapy on the MR-Linac: a multicentre planning challenge on MRIdianplatform (2021) (0)
PO-1296: First MRI Guided Cardiac Radioablation of Sustained Ventricular Tachycardia (2020) (0)
Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen (2022) (0)
Stereotaxic Body Radiotherapy for Stage I NSCLC (2015) (0)
PO-1527 Single-institution analysis of cancer patients treated with multiple courses of repeat radiotherapy (2021) (0)
P04.27 Texture feature analysis to predict overall survival in recurrent glioblastoma treated in the DIRECTOR trial (2017) (0)
Thorax : Lungs and Esophagus (2019) (0)
Are Lung NTCP Models Different In Hypofractionated And Standard Fractionated Radiotherapy (2014) (0)
SP-0482 SGRT - A hype or the new standard of practice? (2021) (0)
PO-1571: Radiomics for prediction of metastatic melanoma patient survival after immunotherapy (2020) (0)
PO-0845: Histopathological findings after irradiation and re-irradiation of spinal bone metastases with SBRT (2018) (0)
EP-1253: Interobserver variability in the target delineation of hepatocellular carcinoma (2017) (0)
48 Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: An International Survey of Practice Patterns (2019) (0)
EP-1261: Impact of sarcopenia on adverse effects in trimodality therapy for esophageal carcinoma (2016) (0)
Real-time Couch Tracking for Prostate Cancer: Toward Submillimeter Accuracy (2010) (0)
Survival outcome of non-small cell lung cancer (NSCLC) patients: Comparing results between the database of the Comprehensive Cancer Center Zürich (CCCZ) and the Epidemiological Cancer Registry Zurich and Zug (KKR) (2019) (0)
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in locally advanced non-small cell lung cancer: a pooled analysis of individual patient data from three randomized trials. (2021) (0)
Long-term cancer survivors treated with multiple courses of repeat radiation therapy (2021) (0)
Repeat stereotactic body radiotherapy for oligometastatic disease. (2023) (0)
PO-1409 Imaging and blood biomarkers in metastatic melanoma patients treated with immunotherapy. (2021) (0)
PD-0741 Application of the ESTRO/EORTC oligometastatic disease classification system to current evidence (2021) (0)
SU-F-R-51: Radiomics in CT Perfusion Maps of Head and Neck Cancer. (2016) (0)
SP-0213: Peripheral lesions: Too much dose? (2014) (0)
Investigating the Reproducibility of Motion for Lung Tumours Treated with Stereotactic Body Radiotherapy (2009) (0)
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. (2023) (0)
Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort. (2016) (0)
OC-0045 GEOMETRIC AND DOSIMETRIC ACCURACY OF FRAME-LESS IMAGE-GUIDED RADIOSURGERY IN CLINICAL PRACTICE (2012) (0)
EP-1414: Toxicity of concurrent stereotactic radiotherapy and targeted or immunotherapy: a systematic review (2017) (0)
Skull Base Tumors (2015) (0)
Value of Patient Immobilization in External Beam Radiotherapy for Prostate Cancer (2014) (0)
PO-1015 Prospective evaluation of anatomical changes of salivary glands during MRI-guided ART for HNC (2021) (0)
Comparison of MR Preprocessing Strategies and Sequences for Radiomics-Based MGMT Prediction (2021) (0)
PO-0861 Analysis of nodal and prostatic bed RT in oligorecurrent PC patients treated with PSMA-PETguided RT (2019) (0)
PO-1803 Voxel-wise quantification of anatomical tumor lung location is associated with overall survival (2021) (0)
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (0)
OC-0135: Can we select stage I NSCLC patients at high risk for early death prior to SBRT treatment? (2016) (0)
OC-0163 Risk classification for PSA relapse after PSMAPET-guided RT for oligorecurrent prostate cancer (2019) (0)
Hypofractionated radiotherapy for prostate cancer (2014) (0)
CT image standardization is superior to larger but heterogeneous data for robust radiomic models. (2019) (0)
Radiation Therapy in Non-small-Cell Lung Cancer (2019) (0)
Kombination zielgerichteter Systemtherapie und zielgerichteter Radiotherapie (2015) (0)
PO-1514: Non-coplanar trajectory VMAT for treatment of spinal metastatic tumors (2020) (0)
FIRE-9 – PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer (2022) (0)
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations. (2023) (0)
MA 13.09 Toxicity and Second Primary Lung Cancers in Late Survivors Following Lung SBRT (2017) (0)
PD-0742 Prognostic Value of The ESTRO EORTC Classification System of Oligometastatic Disease (2021) (0)
SC03.01 Advances in Stereotactic Body Radiotherapy (2017) (0)
Authors' Response to Letter to the Editor "Comments on 'Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study'". (2020) (0)
PO-0864: A planning study investigating different planning techniques for SBRT of NSCLC (2016) (0)
Clinical and Technical Factors For Stereotactic Body Radiotherapy For Gynecological Cancer - Results from An International Radiosurgery Consortium Survey (2017) (0)
Clinical and Technical Factors For Stereotactic Body Radiotherapy For Gynecological Cancer - Results from An International Radiosurgery Consortium Survey (2017) (0)
Risk Factors for spinal Compression Fractures after stereotactic Irradiation of Patients with Spinal Metastases - Results of a Phase 2 Study (2019) (0)
X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (0)
Chance im Konzept des «Cancer as chronic disease» (2017) (0)
A Snapshot of the Practice of Stereotactic Body Radiation Therapy From 30 Centers in 6 Countries (2014) (0)
PC08.05 Debate #2: Keep Calm and Beam On: Thoracic Radiation Obviates the Need for Surgery (2018) (0)
Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy (2021) (0)
[Stereotactic body radiotherapy compared to modern surgery for treatment of early stage non-small-cell lung cancer]. (2022) (0)
FIRE-9 – PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer (2022) (0)
EP-1863: Radiomics in the CT perfusion maps – robustness study (2016) (0)
OC-0593: Dosimetric analysis of local failures in skull-base chordoma/chondrosarcoma following proton therapy (2018) (0)
THU0345 TEXTURE-BASED RADIOMICS FEATURES DISCRIMINATE DIFFERENT STAGES OF EXPERIMENTAL INTERSTITIAL LUNG DISEASE (2019) (0)
Tumour delineation in oesophageal cancer - A comparison study of delineation in PET, CT and based on CT-visual endoscopic clip markers (2014) (0)
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer (2020) (0)
PO-1113 A Set-up comparison between MV imaging and optical surface monitoring for breast cancer patients (2015) (0)
Respiratory motion prediction filters for real time tumor tracking during radiation treatment (2015) (0)
PO-0923 How can a limited number of proton slots be optimally used in combined proton-photon treatments? (2019) (0)
SP-0311: Automated treatment plan generation - the Zurich experience (2016) (0)
Aktuelle interdisziplinäre Behandlung von Knochenmetastasen (2023) (0)
Title: Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa) Running title: Respiratory motion-management in SBRT (2020) (0)
Deﬁning oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document Radiotherapy and Oncology (2020) (0)
PO-1971 Patient experience and gating efficiency using a visual tracking system for breath hold during MRgRT (2021) (0)
PV-0197: Comparison of manual and two automated planning solutions for stereotactic brain radiosurgery (2018) (0)
Leukoencephalopathy after Prophylactic Whole-Brain Irradiation with or without Hippocampal Sparing: A Long-Term MRI Analysis (2019) (0)
Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (0)
OC-0088 Margin calculation for multiple metastases in single-isocenter lung SBRT (2021) (0)
How Much Lung Sparing is Achievable by Adaptive Radiotherapy in Treatment of Advanced-stage Non–small-cell Lung Cancer? (2009) (0)
OC-0265: Effective tumor reoxygenation for combined treatment with radiotherapy (2018) (0)
OC-0206: Dose-response modelling in SBRT for stage I NSCLC and pulmonary metastases based on a multi-institutional database (2015) (0)
[Systemic effects of local radiotherapy: first clinical evidence]. (2021) (0)
OC-0617: A new technique for robust VMAT treatment planning of total craniospinal irradiation (2018) (0)
Immobilization for SBRT: A Crucial Prerequisite Toward Accurate Treatment (2019) (0)
OC-0710: Initial clinical experience with the MR-Linac System – Treatment workflow management (2020) (0)
[Local radiotherapy for patients with newly diagnosed, metastatic prostate cancer]. (2019) (0)
[Which patients with localized prostate cancer benefit from which local procedure and what does "benefit" mean in prostate cancer?] (2018) (0)
Radiosurgery as Primary Treatment for Vertebral Metastases: Results From an International Multicenter Database (2013) (0)
OC-0424: SBRT for Primary Liver Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis (2017) (0)
PO-0818: Feasibility and first experience of MR-guided adaptive radiotherapy for head and neck cancer (2020) (0)
Efficacy and Safety of Metastasis Directed Stereotactic Radiotherapy in NSCLC Patients Progressing Under Targeted- or Immunotherapy. (2020) (0)
Editorial: Precision medicine approaches in radiotherapy and systemic therapy of brain metastases (2023) (0)
EP-1563 PSMA-ligand based radiotherapy for lymph node relapsed prostate cancer after radical prostatectomy (2019) (0)
Variability in spine radiosurgery treatment planning – results of an international multi-institutional study (2016) (0)
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial (2012) (0)
Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis (2021) (0)
OC-0305: Validation of Dynamic Treatment-Couch Tracking for Prostate SBRT (2017) (0)
Electronic Poster: RTT track: Image guided radiotherapy and verification protocolsEP-1842: Comparison between infrared marker and surface imaging for DIBH of left-sided breast treatments (2017) (0)
PO-0879 Mobile health for monitoring of health status in palliative care patients: a feasibility study (2019) (0)
143: The management of patients with extensive-stage small-cell lung cancer: A European survey of practice (2017) (0)
Körperstereotaxie beim NSCLC im Stadium I (2014) (0)
MA06.06 Intracavitary Cisplatin-Fibrin followed by Irradiation after Lung Sparing Surgery in a Rat Model of Malignant Mesothelioma (2021) (0)
[Durvalumab after radiochemotherapy for locally advanced unresectable NSCLC-a breakthrough]. (2019) (0)
A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy (2012) (0)
PO-1928: Initial clinical experience with the MR-Linac System - Patient perspective (2020) (0)
Corrigendum to “Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study” [Phys. Imaging Radiat. Oncol. 22 (2022) 131–136] (2022) (0)
21st Annual SASRO Meeting (2017) (0)
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (0)
PO-1020 Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma (2021) (0)
OC-0526: Can surface guided radiation therapy be used to setup DIBH breast cancer patients to reduce Imaging? (2018) (0)
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (0)
OC-0125: Relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 trial (2017) (0)
PO-0907: TCP modeling in a large cohort of NSCLC patients inclusive of geometric uncertainties (2015) (0)
Risk for surgical complications after previous stereotactic body radiotherapy of the spine (2017) (0)
MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL (2020) (0)
EP-1229 Repeated intracranial radiotherapy/SRTAnalysis of efficacy and safety including EQD2 sum plans (2019) (0)
SP-0343: SBRT for oligometastatic disease: For the motion (2015) (0)
EP-1365 SBRT as salvage therapy for oligometastatic pleural mesothelioma after initial curative therapy (2019) (0)
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. (2023) (0)
Mobile health technology in severely ill patients (2018) (0)
- 1-Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy ; first phantom and clinical results (2010) (0)
Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) (0)
Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (0)
PO-1053 cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer (2022) (0)
431P Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16 (2022) (0)
PO-1648 Cell kill based treatment planning for polymetastatic patients with high tumor burden (2022) (0)
Radiotherapy Versus Chemoradiation in Elderly Head-and-Neck Squamous Cell Carcinoma Patients – A Retrospective International Multicenter Study (2022) (0)
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug. (2020) (0)
PO-1766 Deep learning classifier for MGMT promoter methylation status in glioblastoma cancer (2022) (0)
Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study (2018) (0)
PD-0077 Systemic Therapy-Free Survival after Stereotactic Body Radiotherapy for Oligorecurrent Disease (2022) (0)
OC-0601 Incidence and outcomes of oligometastatic esophagogastric cancer: A multicenter cohort study (2022) (0)
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases (2019) (0)
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases (2018) (0)
Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (0)
OC-0069: Influence of PET radiomics implementation on reproducibility of tumor control prognostic models (2017) (0)
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial (2022) (0)
SP-0412: Does the prescription isodose matter? (2016) (0)
115P Salvage surgery in patients with locally advanced or metastatic non-small cell lung cancer (2023) (0)
SBRT for centrally localized NSCLC – What is too central? (2016) (0)
EP-1386: Mobile health technologies for severely-ill and palliative care patients (2017) (0)
Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy (2020) (0)
PO-1563: New voxel-based approach to study the relation of tumor location and survival in NSCLC (SAKK-16/00) (2020) (0)
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer (2021) (0)
Multimodal treatment in operable stage III non-small cell lung cancer using the new TNM staging classification version 8: Long term results of a pooled analysis of three SAKK trials. (2018) (0)
EP08.03-006 Survival After Radical Treatment of Oligometastatic Non-small Cell Lung Cancer: A Multicenter Analysis (2022) (0)
Stereotactic body radiotherapy for central lung tumours: Author reply. (2015) (0)
Re-irradiation With Stereotactic Radiosurgery Treatment for Spinal Metastases: Results From an International Multicenter Database (2013) (0)
PO-1063 Quality-of-life and perceptions in cancer patients treated with multiple courses of radiotherapy (2022) (0)
Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine (2022) (0)
PO-0981: First experiences with combined EBRT and HDR-brachytherapy boost using Co-60 in patients with prostate cancer (2013) (0)
SP-0530 Against the motion - Photons against Protons (2022) (0)
OC-0139: SBRT for stage I NSCLC: patterns-of-care and outcome analysis in Germany and Austria between 1998 and 2011 (2013) (0)
PD-0083 Benefit of replanning in MR-guided online adaptive radiation therapy in liver metastasis treatment (2022) (0)
A Survival Prediction Tool for Cancer Patients Treated with Stereotactic Radiation Therapy (2022) (0)
Pre-emptive or reactive? PROMPT spinal screening in metastatic castration-resistant prostate cancer. (2022) (0)
MO-0713 Stereotactic Body Radiotherapy for Long Bone Metastases: An International Multicenter Analysis (2022) (0)
MR-guidance in clinical reality: current treatment challenges and future perspectives (2019) (0)
PV-0042: SBRT for peripheral lung tumors >5 cm: first results of the multicenter phase I/II VOLUMES trial (2018) (0)
Identifying core MRI sequences for reliable automatic brain metastasis segmentation (2023) (0)
PD-0820 Explainability of deep learning-based HPV status prediction in oropharyngeal cancer (2022) (0)
Correction to: Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (0)
PD-0153 Comparison of methods for T1-w brain MRI intensity normalization for quantitative MRI analysis (2022) (0)
OC-0041 Gating has small impact on dose to OARs and PTV coverage in MR-guided daily ART of prostate cancer (2022) (0)
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) (0)
OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity (2022) (0)
Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience (2021) (0)
PO-1157 Comprehensive comparison of prognostic scores for patients with newly diagnosed brain metastases (2022) (0)
OC-0934 Outcomes of the EORTC 22922/10925 randomised trial according to the technique for nodal irradiation (2022) (0)
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute toxicity of a randomized phase II trial (2022) (0)
Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (0)
OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis (2022) (0)
Körperstereotaxie und Lobektomie im randomisierten Vergleich beim NSCLC Stadium I – endlich Level-I-Evidenz? (2015) (0)
Oligometastasiertes nichtkleinzelliges Lungenkarzinom: lokaltherapeutische Optionen zur Behandlung von Lungen- und Nebennierenmetastasen (2020) (0)
Wer ist ... Matthias Guckenberger? (2012) (0)
Konzepte beim oligometastasierten Lungenkarzinom (2022) (0)
Stereotaktische Bestrahlung: Lokale Tumorkontrolle enorm verbessert (2014) (0)
Präoperative Kurzzeitradiotherapie kombiniert mit volldosierter Langzeitchemotherapie beim lokal fortgeschrittenen Rektumkarzinom (2015) (0)
SMILE: Stereotaktische MRT-geführte Radiotherapie von lokal begrenzten Prostatakarzinomen (2022) (0)
MASPAC: SBRT zur Schmerzkontrolle beim Pankreaskarzinom (2022) (0)
Stellenwert der 5-FU-basierten adjuvanten Chemotherapie nach präoperativer Radiochemotherapie beim lokal fortgeschrittenen Rektumkarzinom (2014) (0)
Bildgeführte Strahlentherapie (2011) (0)
Wer profitiert von welchem lokalen Vorgehen? (2018) (0)
Postoperative Bestrahlung beim Prostatakarzinom (2016) (0)
Nichtinvasive Therapie des nicht kleinzelligen Bronchialkarzinoms im frühen Stadium mittels Hochpräzisions-Strahlentherapie – eine zukünftige Option nicht nur für inoperable Patienten? (2007) (0)
Einfluss der CT-Simulation auf das Überleben (2012) (0)
Versorgungsforschung in der Radioonkologie am Beispiel der Körperstereotaxie (2017) (0)
Körperstereotaxie beim NSCLC im Stadium I (2013) (0)
Moderne Methoden zur Schonung von Normalgewebe in der Strahlentherapie (2011) (0)
Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie zur Behandlung des NSCLC im Stadium I (2022) (0)
Gesamtüberleben bei Ösophaguskarzinom verlängert sich durch Radiochemotherapie (2013) (0)
CME-Antworten zu den Fragen zu «Palliative Strahlentherapie» aus Praxis Nr. 5 (2016) (0)
[Stereotactic body radiotherapy as "first-line treatment" for oligometastatic renal cell cancer]. (2022) (0)
Prädiktiver Einfluss unterschiedlicher histologischer Subtypen auf die lokale Kontrolle nach stereotaktischer Bestrahlung (SBRT) von Lungenmetastasen bei Patienten mit nicht-kleinzelligem Bronchialkarzinom (NSCLC) im oligometastasierten Stadium (2018) (0)
Durvalumab nach Radiochemotherapie beim lokal fortgeschrittenen inoperablen NSCLC – ein Sprung nach vorn (2019) (0)
“HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer (2017) (0)
Herausforderungen und Chancen in der radioonkologischen Behandlung von Patienten im Alter (2015) (0)
Oligoprogression (2020) (0)
Durvalumab nach Radiochemotherapie (2020) (0)
Radiotherapie: Herausforderungen und Möglichkeiten bei älteren Patienten (2016) (0)
Replik zu «Eine Professur für Palliativmedizin in der Radio-Onkologie?» (2018) (0)
Lokale Tumortherapie (2020) (0)
Wirksamkeit und Verträglichkeit der stereotaktischen Radiotherapie für primäre Lebertumoren in der klinischen Routineanwendung – Eine Patterns-of-Care und ErgebnisAnalyse (2017) (0)
Tumor-adaptierte Radiotherapie bei älteren Patienten (2018) (0)
Multimodale Therapie des Rektumkarzinoms: müssen alle Patienten operiert werden? (2016) (0)
Extrakranielle Stereotaxie von Leber- und Pankreas Tumoren (2015) (0)
SP-0644: How to become a department head - Clinical perspective (2020) (0)
PV-0205: Optimization of combined proton-photon treatments (2018) (0)
SP-0349 Manageable or oligometastatic disease: Evolution of terminology in radiation oncology (2021) (0)
EP-1550: Radiotherapy of PSMA-positive oligometastatic recurrent prostate cancer: a single-center experience (2018) (0)
PH-0125: Intra-fractional stability of MR-guided online adaptive SBRT for prostate cancer (2020) (0)
Adherence to contouring and treatment planning requirements within a multicentric trial -results of the quality assurance of the SAKK 09/10 trial (2022) (0)
[Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?]. (2015) (0)
PV-0200: Benchmark Case results from the EORTC Lungtech trial of SBRT for patients with centrally NSCLC (2018) (0)
PD-0429: CT radiomics differentiates levels of radiocurability in tumor subvolumes in head and neck cancer (2020) (0)
OC-0166 Cumulative metastases volume, not number of brain metastases predicts survival in melanoma patients (2019) (0)
SP-0328: Report on the ESTRO task group on Quality management in radiation therapy (2015) (0)
A Multi-national Report on Methods of Image-guided Stereotactic Body Radiotherapy and Radiosurgery for Vertebral Metastases (2011) (0)
Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer (2018) (0)
PD-0734 Validating Brain Metastases Velocity for survival prediction in patients treated with radiosurgery (2021) (0)
Advances in Radiation Therapy Preface (2018) (0)
Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic (2022) (0)
Patterns of care and outcome analysis of SBRT for colorectal lung and liver metastases in 388 patients with 500 metastases: an analysis of the DEGRO working group Stereotactic Radiotherapy (2017) (0)
Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie (2022) (0)
Principles of Image-Guided Hypofractionated Radiotherapy of Spine Metastases (2016) (0)
[No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression]. (2017) (0)
EP-1697: Does contrast agent influence the prognostic accuracy of CT radiomics based outcome modelling? (2017) (0)
Phase 2, multicenter, randomized study of salvage radiation therapy +/- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15 – GETUG-AFU 34 PROMET trial). (2023) (0)
PV-0043: Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases (2018) (0)
Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer (2017) (0)
68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy at low PSA values ≤ 0.5 ng/ml (2019) (0)
EP-1575: Automated VMAT planning for whole brain irradiation with hippocampus sparing (2017) (0)
OC-0057 Probing spatiotemporal fractionation on the preclinical level (2019) (0)
PD-0872 Second In-field course of stereotactic body radiotherapy for thoracic tumors: a multicentre analysis (2021) (0)
Gene expression inhibition of N-Myc downregulated gene 1 (NDRG1) monitoring and facilitation via transfectional transfer of NDRG1-siRNA constructs into- in vitro-cultured human glioblastoma cells (2011) (0)
PET Radiomics Model Based on Multi-Centre Imaging Data of SAKK 16/00 to Predict Event-Free Survival in Locally Advanced Non-Small Cell Lung Cancer (2019) (0)
95 oral ADAPTATION OF RADIOTHERAPY TO A SHRINKING MACROSCOPIC TUMOR IN ADVANCED STAGE NSCLC DOES NOT UNDERDOSE THE MICROSCOPIC DISEASE AND HAS THE POTENTIAL TO INCREASE TUMOR CONTROL PROBABILITY (2011) (0)
PO-0996: Accuracy of an optical surface monitoring device to reduce daily imaging of breast cancer patients (2017) (0)
Lokale Radiotherapie beim mPC? (2019) (0)
PO-1514 Prospective assessment of employees stress during the COVID-19 pandemic (2021) (0)
Implementing Volumetric Modulated Arc Therapy (VMAT): Initial Dosimetric Results for Retrospective Patient Study (2009) (0)
Stereotactic Body Radiotherapy (SBRT) With Biologically Equivalent Dose > 150 Gy is Associated With Improved Local Control in Patients With Squamous but not Non-Squamous Cell Carcinoma of the Lung: A Multi-Institutional Analysis. (2021) (0)
P05.02 International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC) (2021) (0)
EP-1748: An experimental comparison of advanced respiratory motion management techniques (2016) (0)
PD17-07 DETECTION RATE OF 68GA-PSMA-11 PET/MRI IN PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY AND LOW PSA VALUES ⩽ 0.5 NG/ML (2019) (0)
PV-103 Linking ACROP guidelines to ICRU91: a multicentre study in lung SBRT on prescription and reporting (2019) (0)
P2.05-044 Influence of Technological Advances and Institutional Experience on Outcome of Stereotactic Body Radiotherapy for Lung Metastases: Topic: RT Techniques (2017) (0)
SP-0438 Precision medicine – an opportunity for medical physics and radiation oncology (2019) (0)
EP-1486: Feasibility study of using a radiofrequency tracking system for intra-fractional monitoring during radiosurgery (2015) (0)
Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (0)
Unconscious physiological response of healthy volunteers to dynamic respiration-synchronized couch motion (2017) (0)
Single Fraction Urethra-Sparing Prostate Cancer SBRT: Phase I Results of a Multicenter, Single Arm, Phase I/II Trial (2019) (0)
OC-0523: SBRT for oligo-metastatic liver disease–effect of chemotherapy and histology on local tumor control (2017) (0)
PO-1542 Influence of abdominal air cavities on the dose distribution of daily-adapted plans (2021) (0)
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (0)
PO-1784: Quality Assurance for the adaptive workflow on an MRI Linac (2020) (0)
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (0)
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease (2022) (0)
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy (2018) (0)
OC-0166: Dose of stereotactic radiotherapy, local control and overall survival in cholangiocarcinoma (2018) (0)
Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma (2021) (0)
Evaluation of an automated knowledge based treatment planning system for head and neck (2015) (0)
International Collaborative Propensity-Based Matched Pair Analysis of Operable Early Stage Lung Ancer Patients Treated with Stereotactic Body Radiation Therapy Compared to Resection: Differences in Recurrence and Survival with Prolonged Follow-Up (2017) (0)
PART ONE OPTIMIZATION OF SBRT IN EARLY STAGE NSCLC (0)
EP-2113: Clinical implementation of an optical surface monitoring system(OSMS®, Varian) in breast irradiation (2016) (0)
INFLUENCE OFCONTINUOUS TABLEMOTIONONPATIENTBREATHINGPATTERNS (2010) (0)
EP-1807: Imaging hypoxia with the PET-tracer F-18-fluoromisonidazole (F-MISO) First experience (2014) (0)
IBS12.01 Questions to Be Addressed (2019) (0)
OA12.01 PCI for Radically Treated Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Individual Patient Data of Randomized Trials (2019) (0)
Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. (2022) (0)
Correspondence on Rajyaguru et al. (2018) (0)
76P Robustness of radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR (2018) (0)
SP-0054: Management of lung metastases: Stereotactic body radiotherapy as a non-invasive option (2013) (0)
OC-0059 Stereotactic radiotherapy for oligoprogressive NSCLC: clinical scenarios affecting survival (2019) (0)
Welche Patienten mit lokalisiertem Prostatakarzinom profitieren von welchem lokalen Vorgehen und was bedeutet „profitieren“ beim Prostatakarzinom? (2018) (0)
EORTC recommendations radiotherapy lung cancer 2017 1 European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer (2017) (0)
PH-0050 Detailed analysis of lymphatic progression patterns for oropharyngeal squamous cell carcinoma (2021) (0)
EP-1522 Radiotherapy with or without antihormonal therapy for PSMA-positive oligorecurrent prostate cancer (2019) (0)
EP-1503: Rigid and non-rigid registration dose propagation for brachytherapy treatment combined with radiotherapy (2015) (0)
EP-1366 Repeated thoracic high-dose radiotherapy-Analysis of efficacy and safety including EQD sum plans (2019) (0)
Radiographic Changes After Lung Stereotactic Ablative Radiation Therapy (SABR) - Can We Distinguish Fibrosis From Recurrence? A Systematic Review of the Literature (2012) (0)
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy (2023) (0)
OC-0621: Comparison of perfusion CT parameters and [18F]-FDG uptake in head and neck cancer patients (2015) (0)
SP-0654: What is the limit of hypofractionation? (2018) (0)
PO-1211: Stereotactic radiotherapy combined with immune- or targeted therapy for renal cell cancer patients. (2020) (0)
OP-JNCI210114 1360..1368 (2021) (0)
HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours (2018) (0)
PO-0866: Interactive FALCON workshops reduce variability in contouring treatment volumes for spine SBRT (2018) (0)
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy (2020) (0)
Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer. (2023) (0)
A Set-up comparison between MV imaging and optical surface monitoring for breast cancer patients (2010) (0)
Contouring Quality and Adherence to EORTC-based Protocol Guidelines in the Randomized Phase III SAKK 09/10 Trial for Postoperative Prostate Cancer Radiotherapy: Implications for Treatment Quality and Future Clinical Trials (2020) (0)
OC-0531 Can SGRT be used with open masks to set-up HNC patients and reduce intrafractional motion? (2019) (0)
Current status and recent advances in resection cavity irradiation of brain metastases (2021) (0)
Stereotactic Irradiation of the Pancreas: Case Study of a Patient With Persistent Pancreatic Fistula. (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Matthias Guckenberger?

Matthias Guckenberger is affiliated with the following schools:

University of Zurich

Matthias Guckenberger's Academic­Influence.com Rankings

Why Is Matthias Guckenberger Influential?

Matthias Guckenberger's Published Works

Published Works

What Schools Are Affiliated With Matthias Guckenberger?

Matthias Guckenberger's AcademicInfluence.com Rankings